Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Prostate Cancer
Simple Blood Test Predicts Response to Enzalutamide in Patients With Prostate Cancer
Prostate Cancer
Read More ›
Phi Index Can Select Patients With Prostate Cancer for Active Surveillance
Prostate Cancer
Read More ›
Hormonal Therapy for Prostate Cancer: An Oncologist’s Perspective
By
Winston Tan, MD, FACP
Prostate Cancer
Read More ›
Therapy for Castration-Resistant Prostate Cancer: Use Disease State as the Guide
Prostate Cancer
Read More ›
Enzalutamide Extends Survival in Previously Untreated Metastatic Prostate Cancer
Prostate Cancer
Read More ›
Understanding Molecular Subtypes Is Basis for Genomic Medicine in Prostate Cancer
Prostate Cancer
Read More ›
Budget Impact Model: Epigenetic Assay Can Help Avoid Unnecessary Repeated Prostate Biopsies and Reduce Healthcare Spending
By
Wade Aubry, MD
Prostate Cancer
Read More ›
Prostate and Kidney Cancer News From the 2013 Genitourinary Cancers Symposium
By
Alice Goodman
Prostate Cancer
Read More ›
Targeted Therapies Added to Docetaxel Do Not Extend Survival in Metastatic Prostate Cancer
By
Phoebe Starr
Prostate Cancer
Read More ›
SNPs Identified for Further Study in Association With QOL in Men With Prostate Cancer Treated With Radiation
By
Phoebe Starr
Prostate Cancer
Read More ›
Page 2 of 3
1
2
3